Stock CONTEXT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Context Therapeutics Inc. Nasdaq

Equities

US21077P1084

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-07-16 EDT 		5-day change 1st Jan Change
2.19 USD -0.45% Intraday chart for Context Therapeutics Inc. +12.89% +93.81%
05-08 Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC CI

Chart calendar Context Therapeutics Inc.

8f1eecd17e.KcHsvDU-yDG-kSrp2Zt5WD9OM5ek4x0jLYLy9cnayuU.UfSN6WdWv1TSqGGrsqk1a2svXNqSlUtsQOm3za2486YfqKrKAnb-SP_XHg~b490eff8425c0a4a89b54060c81b3b02

Upcoming events on Context Therapeutics Inc.

2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-18 Q4 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)

Past events on Context Therapeutics Inc.

2024-06-13 08:30 Annual General Meeting
2024-05-08 16:06 Q1 2024 Earnings Release
2024-04-08 14:15 Needham Healthcare Conference
2024-03-21 07:43 Q4 2023 Earnings Release
2023-11-09 16:15 Q3 2023 Earnings Release
2023-11-03 12:00 Society for Immunotherapy of Cancer Meeting - Abstract Number : 1183
2023-08-17 11:30 H.C. Wainwright Immune Cell Engager Conference - Fireside Chat
2023-08-09 16:10 Q2 2023 Earnings Release
2023-08-07 10:30 BTIG Biotechnology Conference - Fireside Chat
2023-05-31 08:30 Annual General Meeting
2023-05-10 16:39 Q1 2023 Earnings Release
2023-04-19 08:45 Needham Healthcare Conference
2023-04-17 09:00 American Association for Cancer Research Meeting - Abstract Number: 1865 / 4
2023-04-05 09:40 Diamond Equity Research Research Emerging Growth Invitational Conference
2023-03-22 17:08 Q4 2022 Earnings Release
2022-12-07 18:00 San Antonio Breast Cancer Symposium - Abstract: 1300819
2022-12-07 18:00 San Antonio Breast Cancer Symposium - Abstract: 1307318
2022-12-01 11:00 R&D Day
2022-11-09 16:14 Q3 2022 Earnings Release
2022-10-26 09:30 ThinkEquity Conference

Upcoming sector events for Context Therapeutics Inc.

2024-07-21 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release
2024-07-22 07:00 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release
2024-07-23 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release
2024-07-23 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release
2024-07-24 LONZA GROUP AG: Q2 2024 Earnings Release
2024-07-25 01:00 BACHEM HOLDING AG: Q2 2024 Earnings Release
2024-07-25 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
2024-07-26 01:00 BB BIOTECH AG: Q2 2024 Earnings Release
2024-07-28 CRISPR THERAPEUTICS AG: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Context Therapeutics Inc.

2024-07-15 01:45 ADDLIFE AB: Q2 2024 Earnings Release
2024-07-10 03:01 SUNMAX BIOTECHNOLOGY CO., LTD.: June 2024 Sales and Revenue Release
2024-07-10 01:51 POLARIS GROUP: June 2024 Sales and Revenue Release
2024-06-11 03:04 SUNMAX BIOTECHNOLOGY CO., LTD.: May 2024 Sales and Revenue Release
2024-06-07 02:57 POLARIS GROUP: May 2024 Sales and Revenue Release
2024-05-29 16:01 IMMUNOVANT, INC.: Q4 2024 Earnings Release
2024-05-23 07:00 CUREVAC N.V.: Q1 2024 Earnings Release
2024-05-22 01:00 EVOTEC SE: Q1 2024 Earnings Release
2024-05-21 17:14 ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. Calendar Context Therapeutics Inc.